LAVVAN is led by one of the most influential, respected and pioneering teams in the global cannabis industry. After the $2.5 billion purchase of MedReleaf Corp. – a company that from 2014 to 2018 was one of the largest legal producers of cannabinoids in the world – the team dedicated itself to once again revolutionizing the industry that it helped to birth, by bringing to it a level of quality, reliability and sustainability that global brands, manufacturers and suppliers can depend on.
Neil Closner
Chief Executive Officer
Etan Bendheim
President
Dr. Jeremy N. Friedberg
Chief Science Officer
Angelo Fefekos
SVP, Regulatory Affairs & Quality Assurance
Adam Noyek
SVP, Operations
Daniel Goldberg
SVP, Corporate Development
Jason Fleming, CHRE
VP, Human Resources
Umar Syed
Senior Advisor, Product Strategy
Alexia Blake
Director, Product Development
Istok Nahtigal
Director, Process Sciences
Ori Sher
VP, Infrastructure & Security